Your browser doesn't support javascript.
loading
Associations of mortality and cardiovascular disease risks with diabetes and albuminuria in urban Indigenous Australians: the DRUID follow-up study.
Barr, E L M; Cunningham, J; Tatipata, S; Dunbar, T; Kangaharan, N; Guthridge, S; Li, S Q; Condon, J R; Shaw, J E; O'Dea, K; Maple-Brown, L J.
Afiliação
  • Barr ELM; Menzies School of Health Research, Darwin, Australia.
  • Cunningham J; Baker Heart and Diabetes Institute, Melbourne, Australia.
  • Tatipata S; Menzies School of Health Research, Darwin, Australia.
  • Dunbar T; Menzies School of Health Research, Darwin, Australia.
  • Kangaharan N; Charles Darwin University, Darwin, Australia.
  • Guthridge S; Royal Darwin Hospital, Darwin, Australia.
  • Li SQ; Menzies School of Health Research, Darwin, Australia.
  • Condon JR; Health Gains Planning, Northern Territory Department of Health, Darwin, Australia.
  • Shaw JE; Health Gains Planning, Northern Territory Department of Health, Darwin, Australia.
  • O'Dea K; Menzies School of Health Research, Darwin, Australia.
  • Maple-Brown LJ; Baker Heart and Diabetes Institute, Melbourne, Australia.
Diabet Med ; 34(7): 946-957, 2017 07.
Article em En | MEDLINE | ID: mdl-28375555
ABSTRACT

AIM:

To assess the relationships of diabetes and albuminuria with all-cause mortality and cardiovascular disease outcomes in a population without prior cardiovascular disease using data from the Darwin Region Urban Indigenous Diabetes (DRUID) study.

METHODS:

We conducted a prospective cohort study of 706 participants (aged 15-81 years, 68% women) without prior cardiovascular disease who underwent a 75-g oral glucose tolerance test. Deaths and fatal or non-fatal cardiovascular disease were determined over 7 years, and hazard ratios with 95% CIs and population attributable risks were estimated for baseline glycaemia and albuminuria.

RESULTS:

Compared with normoglycaemia and after adjustment for age, sex, hypertension, dyslipidaemia and smoking, known diabetes was associated with an adjusted hazard ratio of 4.8 (95% CI 1.5-14.7) for all-cause mortality and 5.6 (95% CI 2.1-15.2) for cardiovascular disease. Compared with normoalbuminuria, the respective adjusted risks for macroalbuminuria were 10.9 (95% CI 3.7-32.1) and 3.9 (95% CI 1.4-10.8). The Adjusted all-cause mortality and cardiovascular disease estimated population attributable risks for diabetes were 27% and 32%, and for albuminuria they were 32% and 21%, respectively.

CONCLUSIONS:

In our study population, the burden of mortality and cardiovascular disease was largely driven by diabetes and albuminuria. This finding on the influence of diabetes and albuminuria is consistent with reports in other high-risk Indigenous populations and should be better reflected in risk scores and intervention programmes.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Saúde da População Urbana / Angiopatias Diabéticas / Nefropatias Diabéticas / Insuficiência Renal Crônica / Cardiomiopatias Diabéticas Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Saúde da População Urbana / Angiopatias Diabéticas / Nefropatias Diabéticas / Insuficiência Renal Crônica / Cardiomiopatias Diabéticas Idioma: En Ano de publicação: 2017 Tipo de documento: Article